TAK· Takeda Pharmaceutical Co. Ltd.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
TAK Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$52.0B
Enterprise value$4794.2B
EV / EBITDA (TTM)3.76
P/E ratio (TTM)71.57
Forward P/E31.06
P/S ratio0.01
P/B ratio1.09
PEG ratio0.33
Cash Flow
Operating cash flow (TTM)$1189.1B
Free cash flow (TTM)$536.7B
Total cash$654.9B
Total debt$5422.0B
Debt / equity70.93
Current ratio1.19
Income Statement
Total revenue (TTM)$4464.6B
Revenue per share (TTM)1417.23
Gross profit (TTM)$2925.4B
EBITDA (TTM)$1274.0B
Net income (TTM)$112.9B
EPS diluted (TTM)0.23
Shares outstanding3,159,192,822
Float shares1,577,937,835
Profitability
Gross margin65.53%
Operating margin10.85%
EBITDA margin28.54%
Net margin2.53%
Efficiency
Return on assets (TTM)2.47%
Return on equity (TTM)1.50%
Price History
Current price$16.46
52 Week high$18.90
52 Week low$12.99
50 day average$17.69
200 day average$15.83
Average volume (10 day)2,748,030
1-year beta0.10
1-year price target$20.75
Dividends
Dividend yield4.02%
Dividend rate (annual)$0.66
Payout ratio279.05%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:42 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com